Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic Models.

ABSTRACT: There is a need for new approaches and endpoints in oncology drug development, particularly with the advent of immunotherapies and the multiple drug combinations under investigation. Tumor dynamics modeling, a key component to oncology "model-informed drug development," has shown a growing number of applications and a broader adoption by drug developers and regulatory agencies in the past years to support drug development and approval in a variety of ways. Tumor dynamics modeling is also being investigated in personalized cancer therapy approaches. These models and applications are reviewed and discussed, as well as the limitations and issues open for further investigations. A close collaboration between stakeholders like clinical investigators, statisticians, and pharmacometricians is warranted to advance clinical cancer therapeutics.

SUBMITTER: Bruno R 

PROVIDER: S-EPMC8415106 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature